Sign Up to like & get
recommendations!
0
Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.3813
Abstract: Effective second‐line chemotherapy options are limited in treating advanced biliary tract cancers (BTCs). Resminostat is an oral histone deacetylase inhibitor. Such inhibitors increase sensitivity to fluorouracil, the active form of S‐1. In the phase I…
read more here.
Keywords:
biliary tract;
resminostat;
study;
histone deacetylase ... See more keywords